Blocking two proteins reverses lung scarring in pre-clinical study
A Virginia Tech team has identified a promising new therapeutic strategy for idiopathic pulmonary fibrosis (IPF), showing that blocking two proteins can halt and even reverse lung scarring in pre-clinical models.
3 hours ago
0
1









